Eiger BioPharmaceuticals Inc. (EIGR) Fell -5.52% or -0.75 To Price $12.85 On Monday


Eiger BioPharmaceuticals Inc. (EIGR) fell -5.52% or -0.75 to $12.85. It is approximately 80550 shares traded, which is 26.0% compare to the average total volume 309806. The market cap of EIGR is $135.44 million. The year to date change is -8.72%. The 52 week price range is from $6.9 to $18.0. Price of EIGR have changed -5.56% during last week. It have changed 3.82% over last month, 33.99% over last 3 months, -3.89% over last 6 months and 94.29% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for EIGR is 12.14. It is -5.53% below current price. The 200-day Moving Averages for EIGR is 11.14. It is -13.31% below current price. The 52-week High is 18.0. It is 40.08% from the current price. The 52-week Low is 6.9. It is -46.30% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of EIGR is 0.29 on 2018-05-31. Short % to float is 1.01%. There are some statistics of EIGR. It is has market cap $135.44 million. The share outstanding is 10.54 million. The average volume is 309806. The percent of top 15 Institution holding is 37.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of EIGR is -175.61%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of EIGR is -95.35%.


Tags:

Share this post